Showing 34,867 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP policies & guidelines

Statement in response to Department of Health and Social Care fully-funding roll-out of PrEP

Editor's pick
National AIDS Trust
15 March 2020

КРОИ 2020: Долутегравир-содержащие схемы является самым безопасным и наиболее эффективным вариантом АРВТ для беременных женщин, 13 марта 2020

March 2020

CROI 2020: Il trattamento con dolutegravir è l’opzione terapeutica più sicura ed efficace in gravidanza, 13 marzo 2020

March 2020

CROI 2020: El tratamiento antirretroviral basado en dolutegravir constituye la opción más segura y eficaz para las mujeres con el VIH embarazadas, 13 de marzo de 2020

March 2020
Treatment outcomes & life expectancy

Yes, the same life expectancy as HIV-negative people, but far fewer years in good health

News
13 March 2020
Transgender people

Unique transgender vulnerabilities require tailored and specific interventions

News
13 March 2020

CROI 2020: O tratamento para o VIH com dolutegravir é a escolha mais segura e eficaz para mulheres grávidas, 13 de março de 2020

March 2020

CROI 2020: Le traitement anti-VIH à base de dolutégravir est le choix le plus sûr et le plus efficace pour les femmes enceintes, 13 mars 2020

March 2020
PrEP science

Taking PrEP during acute HIV infection for more than 2-3 weeks is likely to cause resistance, Thai study finds

News
13 March 2020
Coronavirus

Corona virus (COVID-19) and HIV – update from the British HIV Association

Editor's pick
BHIVA
13 March 2020
Coronavirus

Experts shed light on coronavirus response and its implications for people with HIV

News
13 March 2020

CROI 2020: Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women, 13 March 2020

March 2020
Pregnancy and vertical transmission

SEARCH study finds universal 'test and treat' reduces infant HIV

News
13 March 2020
The search for a cure

Attack on HIV Reservoir Falls Short

Editor's pick
MedPage Today (free registration required)
13 March 2020
HIV & criminal law

Georgia Moves Closer to Major Overhaul of HIV Criminal Law

Editor's pick
New York Times
13 March 2020
Coronavirus

South Korea experts recommend anti-HIV, anti-malaria drugs for COVID-19

Editor's pick
UPI
13 March 2020
New & experimental HIV treatments

Long-acting capsid inhibitor GS-6207 confirms safety and antiviral activity

News
12 March 2020
The search for an HIV prevention vaccine

HIV vaccine that generates broadly neutralising antibodies passes first safety and proof-of-concept study in humans

News
12 March 2020
Coronavirus

Making Sense of COVID19

Editor's pick
Australian Federation of AIDS Organisations
12 March 2020
Coronavirus

Coronavirus: What you need to know if you have HIV, diabetes or TB

Editor's pick
Bhekisisa
12 March 2020
Bad science & bogus treatments

HIV conspiracy theories and the virus continue to thrive in Russia

Editor's pick
Los Angeles Times
12 March 2020
Treatment for women

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women

News
12 March 2020
Lung disease

Younger people with HIV lose lung function faster

News
12 March 2020
HIV treatment for children & young people

One third of adolescents and young adults on ART in Kenya are not virally suppressed

News
12 March 2020